MicroRNAs in Dopamine Agonist-Resistant Prolactinoma
نویسندگان
چکیده
منابع مشابه
A case of a prolactinoma resistant to dopamine agonists.
Dopamine agonists are the drugs of choice in the treatment of prolactinomas, the most common type of pituitary adenomas. However, up to 25% of prolactinomas do not respond to these drugs and alternative treatments have to be considered. We describe a 37-year old female with a microprolactinoma who, although having received all available formulations of dopamine agonists over a period of 11 year...
متن کاملDelayed presentation of late-onset cerebrospinal fluid rhinorrhoea following dopamine agonist therapy for giant prolactinoma
UNLABELLED Therapeutic shrinkage of prolactinomas with dopamine agonists achieves clinical benefit but can expose fistulae that have arisen as a result of bony erosion of the sella floor and anterior skull base by the invasive tumour, resulting in the potential development of cerebrospinal fluid (CSF) rhinorrhoea, meningitis, and rarely pneumocephalus. Onset of symptoms is typically within 4 mo...
متن کاملSuccessful Improvement of Metabolic Disorders, Including Osteopenia, by a Dopamine Agonist in a Male Patient with Macro-Prolactinoma
BACKGROUND Bone metabolic disorders in patients with prolactinoma have not been fully characterized. The case presented herein illustrates potential causal associations between prolactinoma and osteopenia, with a reversal of the disorder by treatment with a dopamine agonist. CASE REPORT A 43-year-old male with macro-prolactinoma [PRL 7770 ng/mL] was referred to our hospital. He suffered was o...
متن کاملDopamine agonist withdrawal syndrome in Parkinson's disease.
OBJECTIVES To report and characterize a dopamine agonist (DA) withdrawal syndrome (DAWS) in Parkinson disease. DESIGN Retrospective cohort study. SETTING Outpatient tertiary movement disorders clinic. Patients A cohort of 93 nondemented patients with Parkinson disease enrolled in a prospective study of nonmotor and motor disease manifestations. Main Outcome Measure The presence of DAWS, def...
متن کاملDopamine Agonist Therapy in Advanced Parkinson’s Disease
“Parkinson’s disease (PD) doesn’t kill you, it takes your life away.” This is a disturbing quotation by the English Parkinson Lay Organisation. There is, however, no other neurodegenerative disease which responds better to treatment than PD. Treatment of advanced PD is located between these poles (Figure 1). Most national guidelines and papers on the treatment of PD recommended that early phase...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Neuroendocrinology
سال: 2021
ISSN: 0028-3835,1423-0194
DOI: 10.1159/000517356